FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.476",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2024-08-13T01:10:00.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-08-13"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-08-13"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.476"
    }
  ],
  "version": "20240813",
  "name": "OGTT_Grouping",
  "title": "OGTT_Grouping",
  "status": "active",
  "date": "2024-08-13T01:10:00-04:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.471"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.474"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:eac87492-c3bc-40e7-8be4-4a692d2f55f7",
    "timestamp": "2025-05-23T20:28:12-04:00",
    "total": 16,
    "contains": [
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1496-9",
        "display": "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1507-3",
        "display": "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1518-0",
        "display": "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1533-9",
        "display": "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1539-6",
        "display": "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "21004-7",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "49688-5",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "50667-5",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "62856-0",
        "display": "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "6749-6",
        "display": "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "82951",
        "display": "Glucose; tolerance test (GTT), 3 specimens (includes glucose)"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LA33717-2",
        "display": "Impaired glucose tolerance"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LP112419-9",
        "display": "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LP65536-2",
        "display": "Glucose tolerance 3H panel"
      },
      {
        "system": "http://hl7.org/fhir/sid/icd-10-cm",
        "version": "2025",
        "code": "R73.0",
        "display": "Abnormal glucose"
      },
      {
        "system": "http://hl7.org/fhir/sid/icd-10-cm",
        "version": "2025",
        "code": "R73.02",
        "display": "Impaired glucose tolerance (oral)"
      }
    ]
  }
}